VINCA ALKALOID TOXICITY
Tracking # 20-1056122
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
VINCA ALKALOIDS, WHICH BELONG TO A CLASS OF CELL CYCLE PHASE M SPECIFIC ANTI-TUBULIN AGENTS ARE ONE OF THE FIRST PLANT ALKALOIDS TO BE DEVELOPED FOR USE AS ANTI-CANCER AGENTS IN HUMANS. THIS ACTIVITY DESCRIBES THE INCIDENCE, ETIOLOGY, CLINICAL FEATURES, EXAMINATION FINDINGS, DIFFERENTIAL DIAGNOSIS, ASSESSMENT, AND MANAGEMENT OF SYSTEMIC EFFECTS OF VINCA ALKALOIDS, WITH AN EMPHASIS ON VINCRISTINE-INDUCED NEUROTOXICITY.
Subject areas
This course counts toward the state boards and subject areas below.
Bahamas Medical Council
Specialty Medical Practitioner
1h
General Medicine
Louisiana State Board of Medical Examiners - Physicians & Surgeons
Physician & Surgeon
1h
Category I CME
Mississippi State Board of Medical Licensure
Medical Doctor
1h
AMA Category I
Physician Assistant
1h
AMA Category I
State Medical Board of Ohio
Doctor of Medicine
1h
AMA Category I